Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

Similar articles for PubMed (Select 11157640)

1.

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D.

Chest. 2001 Jan;119(1 Suppl):8S-21S. Review. No abstract available.

PMID:
11157640
2.

The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.

[No authors listed]

J Am Geriatr Soc. 2000 Feb;48(2):224-7. No abstract available.

PMID:
10682955
3.

The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.

American Geriatrics Society Clinical Practice Committee.

J Am Geriatr Soc. 2002 Aug;50(8):1439-45; discussion 1446-7. No abstract available.

PMID:
12165003
4.

Ximelagatran.

Choudhury A, Goyal D, Lip GY.

Drugs Today (Barc). 2006 Jan;42(1):3-19. Review.

PMID:
16511607
5.

Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Hirsh J, Dalen JE, Deykin D, Poller L.

Chest. 1992 Oct;102(4 Suppl):312S-326S. Review. No abstract available.

PMID:
1345417
6.

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Hirsh J, Fuster V.

Circulation. 1994 Mar;89(3):1469-80. No abstract available. Erratum in: Circulation 1995 Jan 15;91(2):A55-A56.

PMID:
8124830
7.

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D, Brandt JT.

Chest. 1998 Nov;114(5 Suppl):445S-469S. Review. No abstract available.

PMID:
9822057
8.

Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.

Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.

PMID:
19597069
9.

[Current management of oral anticoagulant treatment].

Pengo V, Prisco D, Iliceto S.

Ital Heart J Suppl. 2002 May;3(5):502-17. Review. Italian.

PMID:
12064189
10.

Warfarin--indications, risks and drug interactions.

Tadros R, Shakib S.

Aust Fam Physician. 2010 Jul;39(7):476-9. Review.

11.

The pharmacogenetics of coumarin therapy.

Voora D, McLeod HL, Eby C, Gage BF.

Pharmacogenomics. 2005 Jul;6(5):503-13. Review.

PMID:
16014000
12.

Coumarin therapy in thrombosis.

Pineo G, Hull RD.

Hematol Oncol Clin North Am. 2003 Feb;17(1):201-16, viii. Review.

PMID:
12627669
13.

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

Mohapatra R, Tran M, Gore JM, Spencer FA.

Am Heart J. 2005 Jul;150(1):19-26. Review.

PMID:
16084146
14.

[Anticoagulation by oral treatment with vitamin K antagonists].

Kemkes-Matthes B.

Hamostaseologie. 2008 Dec;28(5):421-7. German.

PMID:
19132171
15.

Oral anticoagulation: challenges in the case-management setting.

Lowery S, Haley K, Bussey HI.

Lippincotts Case Manag. 2005 Jan-Feb;10(1):39-50. Review.

PMID:
15685010
16.

[Factors influencing activity of oral anticoagulants. Interactions with drugs and food].

Sawicka-Powierza J, Rogowska-Szadkowska D, Ołtarzewska AM, Chlabicz S.

Pol Merkur Lekarski. 2008 May;24(143):458-62. Review. Polish.

PMID:
18634396
17.

Mechanism of action and pharmacology of unfractionated heparin.

Hirsh J, Anand SS, Halperin JL, Fuster V.

Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1094-6. No abstract available.

18.

Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H.

Chest. 1995 Oct;108(4 Suppl):231S-246S. Review. No abstract available.

PMID:
7555179
19.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
20.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk